EAGAN, Minn.--(BUSINESS WIRE)--Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.
EAGAN, Minn.--(BUSINESS WIRE)--Biothera announced today that it has acquired the anti-cancer monoclonal antibody AS1402 from Antisoma for undisclosed terms.